Get Guardian on GoogleMedical experts from across the African continent will converge on Grand Palace Hotel Lusuka, Zambia, from November 27-28, 2026, for the Second African Helicobacter Pylori and Microbiota Conference, where they will brainstorm on opportunities and challenges in helicobacter pylori.
Renowned Emeritus Professor of Medicine at the Trinity College Dublin and Tallagent University Hospital Ireland, Colm O’Morain, will present the keynote address at the conference.
A press statement made available to The Guardian, signed by the President of the African Helicobacter and Microbiota Study Group (AHMSG), Prof. Mashiko Setshedi, said O’ Morain will be speaking on ‘The next 40 years of H.pylori – Opportunities and Challenges.
The statement added that another globally renowned physician, microbiologist and research specialist in Helicobacter/gastro cancer pathogens, Prof. Yoshio Yamaoka, is also billed to speak at the conference.
Setshedi stated Yamaoka will be speaking on ‘Collaborative Research in Africa: Current Progress and Future Perspective.”
He said the two-day scientific conference will also feature good will messages from Prof. Peter Malfertheiner, Richen Symposium, oral presentations, panel discussions, award/prize presentations for best oral presentation, AHMSG presidential handover and AHMSG Board Members meeting.
The AHMSG was launched in Lagos, Nigeria through a series of collective steps to tackle the specific challenges of Helicobacter Pylori infections and gastric health across the African continent.
It was inaugurated by Prof. Babatunde Lawal Salako, the Director General of the Nigerian Institute of Medical Research.
The body was formed as an international coalition, originally bringing together leading medical scholars, with its board members drawn from across African countries including Nigeria, South Africa, Cameroon, Egypt, Kenya, Morocco, Senegal and Tanzania.
Recognising that existing international medical guidelines failed to account for Africa’s distinct socio-economic realities such as limited local funding, poor healthcare access and underdeveloped diagnostic infrastructure, AHMSG was built to create tailored, continent-specific guidelines for diagnosing, preventing and treating H. Pylori infections to ultimately reduce related conditions like stomach ulcers and gastric cancer.
Its second scientific conference is ultimately geared towards achieving these objectives.
